{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:51:24Z","timestamp":1793296284647,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA241758"],"award-info":[{"award-number":["R01 CA241758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA259173"],"award-info":[{"award-number":["R01 CA259173"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA273031"],"award-info":[{"award-number":["R01 CA273031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000918","name":"New York Community Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CER-2019C2-17372"],"award-info":[{"award-number":["CER-2019C2-17372"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CER-2019C1-15682"],"award-info":[{"award-number":["CER-2019C1-15682"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ucl.2026.02.008","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:54:23Z","timestamp":1773816863000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Managing Prostate Cancer Biochemical Recurrence after Definitive Local Therapy"],"prefix":"10.1016","volume":"53","author":[{"given":"Joshua","family":"Winograd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Suzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2005.04.0756","article-title":"Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition","volume":"24","author":"Stephenson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib2","first-page":"e17112","article-title":"Biochemical recurrence (BCR) and outcomes in patients (pts) with prostate cancer (PC) following radical prostatectomy (RP)","volume":"41","author":"Khan","year":"2023","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.ucl.2026.02.008_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2967\/jnumed.120.261886","article-title":"Diagnostic performance and clinical impact of 68Ga-PSMA-11 PET\/CT imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA study)","volume":"63","author":"Cerci","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ucl.2026.02.008_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/cancers16040764","article-title":"How the management of biochemical recurrence in prostate cancer will be modified by the concept of anticipation and incrementation of therapy","volume":"16","author":"Sciarra","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ucl.2026.02.008_bib6","first-page":"5577","article-title":"Fear of cancer recurrence and PSA anxiety in patients with prostate cancer: a systematic review","volume":"30","author":"James","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ucl.2026.02.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2021.11.005","article-title":"Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: the phoenix definition and beyond","volume":"166","author":"Ma","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2019.01.048","article-title":"Persistent prostate-specific antigen after radical prostatectomy and its impact on oncologic outcomes","volume":"76","author":"Preisser","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/cancers13050948","article-title":"Prognostic significance of prostate-specific antigen persistence after radical prostatectomy: a systematic review and meta-analysis","volume":"13","author":"Kimura","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ucl.2026.02.008_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ucl.2026.02.008_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ucl.2026.02.008_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/JU.0000000000001036","article-title":"Competing risks of mortality among men with biochemical recurrence after radical prostatectomy","volume":"204","author":"Daskivich","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib15","article-title":"The impact of positive surgical margin parameters and pathological stage on biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis","volume":"19","author":"Guo","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ucl.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"Psma PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ucl.2026.02.008_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/JU.0000000000001369","article-title":"Detection rate of prostate specific membrane antigen tracers for positron emission tomography\/computerized tomography in prostate cancer biochemical recurrence: a systematic review and network meta-analysis","volume":"205","author":"Crocerossa","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s00259-020-05143-9","article-title":"[18F]DCFPyL PET\/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng\/mL","volume":"48","author":"Perry","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ucl.2026.02.008_bib19","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/pon.5471","article-title":"Risk and associated factors of depression and anxiety in men with prostate cancer: results from a German multicenter study","volume":"29","author":"Esser","year":"2020","journal-title":"Psychooncology"},{"key":"10.1016\/j.ucl.2026.02.008_bib20","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1002\/cncr.33836","article-title":"Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: a longitudinal study","volume":"127","author":"Meissner","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ucl.2026.02.008_bib21","first-page":"32","article-title":"Fear of cancer recurrence: a practical guide for clinicians","volume":"32","author":"Butow","year":"2018","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ucl.2026.02.008_bib22","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1200\/JCO.19.00572","article-title":"Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis","volume":"37","author":"Tauber","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib23","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.3390\/cancers14174078","article-title":"Active observation of biochemical recurrence without treatment following radical prostatectomy: long-term analysis of outcomes","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ucl.2026.02.008_bib24","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1200\/JCO.23.00857","article-title":"Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for integrative Oncology-ASCO guideline","volume":"41","author":"Carlson","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib25","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ijrobp.2019.01.006","article-title":"Utilization of salvage radiation therapy for biochemical recurrence after radical prostatectomy","volume":"104","author":"Hawken","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ucl.2026.02.008_bib26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ucl.2026.02.008_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/JU.0000000000003891","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part II: treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"issue":"16","key":"10.1016\/j.ucl.2026.02.008_bib29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","article-title":"Improved outcomes with enzalutamide in biochemically recurrent prostate cancer","volume":"389","author":"Freedland","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ucl.2026.02.008_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/cancers17020215","article-title":"Early versus delayed androgen deprivation therapy for biochemical recurrence after local curative treatment in non-metastatic hormone-sensitive prostate cancer: a systematic review of the literature","volume":"17","author":"Karim","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ucl.2026.02.008_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jamaoncol.2015.4917","article-title":"Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy","volume":"2","author":"Sun","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamaoncol.2015.2895","article-title":"Intermittent vs continuous androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis","volume":"1","author":"Magnan","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib33","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1245\/s10434-022-11892-8","article-title":"Anti-androgen therapy overcomes the time delay in initiation of salvage radiation therapy and rescues the oncological outcomes in men with recurrent prostate cancer after radical prostatectomy: a post hoc analysis of the RTOG-9601 trial data","volume":"29","author":"Sood","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib34","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S1470-2045(19)30486-3","article-title":"Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial","volume":"20","author":"Carrie","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib35","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2012.01.022","article-title":"Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature","volume":"61","author":"Chade","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib36","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.3390\/cancers15143734","article-title":"The role of salvage radical prostatectomy in patients with radiation-resistant prostate cancer","volume":"15","author":"Drobner","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ucl.2026.02.008_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2025.03.009","article-title":"Outcomes of salvage robotic-assisted radical prostatectomy: high-Volume multicentric data from the European Association of Urology robotic Urology Section Scientific Working Group","author":"Covas Moschovas","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib38","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JU.0000000000001939","article-title":"Comparative outcomes of salvage retzius-sparing versus standard robotic prostatectomy: an international, multi-surgeon series","volume":"206","author":"Kowalczyk","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/JU.0000000000000327","article-title":"Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches","volume":"202","author":"Gontero","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.02.008_bib41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/pros.24551","article-title":"Local salvage of radiorecurrent prostate cancer","volume":"83","author":"Henderson","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2026.02.008_bib42","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3390\/cancers16183225","article-title":"The role of whole-gland and focal cryotherapy in recurrent prostate cancer","volume":"16","author":"Pio","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ucl.2026.02.008_bib43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijrobp.2022.06.080","article-title":"Extended results and independent validation of a phase 2 trial of metastasis-directed therapy for molecularly defined oligometastatic prostate cancer","volume":"114","author":"Glicksman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ucl.2026.02.008_bib44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/ijc.35052","article-title":"Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial","volume":"155","author":"See","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ucl.2026.02.008_bib46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamaoncol.2020.7671","article-title":"Validation of a 22-Gene genomic classifier in patients with recurrent prostate cancer: an ancillary study of the NRG\/RTOG 9601 randomized clinical trial","volume":"7","author":"Feng","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ucl.2026.02.008_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2022.12.035","article-title":"Analysis of a biopsy-based genomic classifier in high-risk prostate cancer: meta-analysis of the NRG oncology\/radiation therapy oncology group 9202, 9413, and 9902 phase 3 randomized trials","volume":"116","author":"Nguyen","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ucl.2026.02.008_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432600008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432600008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:20:59Z","timestamp":1776446459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009401432600008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S009401432600008X"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2026.02.008","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing Prostate Cancer Biochemical Recurrence after Definitive Local Therapy","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2026.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}